Enterprise Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Enterprise Therapeutics's estimated annual revenue is currently $2.5M per year.
- Enterprise Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Enterprise Therapeutics has 16 Employees.
- Enterprise Therapeutics grew their employee count by 0% last year.
Enterprise Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Development | Reveal Email/Phone |
3 | Head Biology | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | Project Director | Reveal Email/Phone |
6 | Office Manager | Reveal Email/Phone |
Enterprise Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Enterprise Therapeutics?
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life. The leadership team has significant expertise in drug discovery, drug development, respiratory biology and ion channel pharmacology. The company benefits from a close working relationship with the School of Life Sciences at the University of Sussex.
keywords:N/A
N/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Enterprise Therapeutics News
He will retain his role as Chief Financial Officer for the private life science company Enterprise Therapeutics, and he remains as a...
... Small and Medium Enterprise Status for the European Union. CALGARY, Alberta, April 20, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc.
Cyclo Therapeutics Enters Research and Collaboration Agreement with Wits Commercial Enterprise (Pty) Ltd to Explore Potential Applications...
Other Companies in Brighton
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 16 | -36% | N/A |
#2 | $1.4M | 16 | -24% | N/A |
#3 | $1.4M | 16 | N/A | N/A |
#4 | $1.4M | 16 | -16% | N/A |
#5 | $2M | 16 | -70% | N/A |